Although the exact mechanism by which the ACE I/D polymorphism affects cardiac adaptations is not fully understood, the renin-angiotensin system (RAS) and associated microRNAs are thought to play a central role by regulating expression throughout the molecular pathways of cardiac hypertrophy [101,102]. The gene discussed is ACE; the disease is cardiac hypertrophy.